These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 22786987)

  • 1. Radiofrequency ablation of lung tumors: imaging features of the postablation zone.
    Abtin FG; Eradat J; Gutierrez AJ; Lee C; Fishbein MC; Suh RD
    Radiographics; 2012; 32(4):947-69. PubMed ID: 22786987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome?
    Yoo DC; Dupuy DE; Hillman SL; Fernando HC; Rilling WS; Shepard JA; Siegel BA
    AJR Am J Roentgenol; 2011 Aug; 197(2):334-40. PubMed ID: 21785078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic response to radiofrequency ablation of neoplastic lesions: FDG PET/CT findings.
    Purandare NC; Rangarajan V; Shah SA; Sharma AR; Kulkarni SS; Kulkarni AV; Dua SG
    Radiographics; 2011; 31(1):201-13. PubMed ID: 21257942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results.
    Okuma T; Okamura T; Matsuoka T; Yamamoto A; Oyama Y; Toyoshima M; Koyama K; Inoue K; Nakamura K; Inoue Y
    Ann Nucl Med; 2006 Feb; 20(2):115-21. PubMed ID: 16615420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
    Singnurkar A; Solomon SB; Gönen M; Larson SM; Schöder H
    J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency ablation of non-small-cell carcinoma of the lung under real-time FDG PET CT guidance.
    Schoellnast H; Larson SM; Nehmeh SA; Carrasquillo JA; Thornton RH; Solomon SB
    Cardiovasc Intervent Radiol; 2011 Feb; 34 Suppl 2():S182-5. PubMed ID: 20508937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Maximum standardized uptake value is more reliable than size measurement in early follow-up to evaluate potential pulmonary malignancies following radiofrequency ablation.
    Alafate A; Shinya T; Okumura Y; Sato S; Hiraki T; Ishii H; Gobara H; Kato K; Fujiwara T; Miyoshi S; Kaji M; Kanazawa S
    Acta Med Okayama; 2013; 67(2):105-12. PubMed ID: 23603927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of PET/Computed Tomography in Radiofrequency Ablation for Malignant Pulmonary Tumors.
    Higuchi M; Suzuki H; Gotoh M
    PET Clin; 2016 Jan; 11(1):47-55. PubMed ID: 26590443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorodeoxyglucose positron emission tomography for detection of tumor recurrence following radiofrequency ablation in retrospective cohort of stage I lung cancer.
    Wang Y; Lanuti M; Bernheim A; Shepard JO; Sharma A
    Int J Hyperthermia; 2018; 35(1):1-8. PubMed ID: 29719997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in fluorodeoxyglucose positron emission tomography activity following complete radiofrequency ablation of lung tumors.
    Sharma A; Lanuti M; He W; Palmer EL; Shepard JA; Digumarthy SR
    J Comput Assist Tomogr; 2013; 37(1):9-14. PubMed ID: 23321827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency ablation of advanced lung tumors: imaging features, local control, and follow-up protocol.
    Wang Y; Li G; Li W; He X; Xu L
    Int J Clin Exp Med; 2015; 8(10):18137-43. PubMed ID: 26770411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results.
    Veit P; Antoch G; Stergar H; Bockisch A; Forsting M; Kuehl H
    Eur Radiol; 2006 Jan; 16(1):80-7. PubMed ID: 15868122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI and CT characteristics of successfully ablated renal masses: Imaging surveillance after radiofrequency ablation.
    Davenport MS; Caoili EM; Cohan RH; Ellis JH; Higgins EJ; Willatt J; Fox GA
    AJR Am J Roentgenol; 2009 Jun; 192(6):1571-8. PubMed ID: 19457820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early PET/CT after radiofrequency ablation in colorectal cancer liver metastases: is it useful?
    Liu ZY; Chang ZH; Lu ZM; Guo QY
    Chin Med J (Engl); 2010 Jul; 123(13):1690-4. PubMed ID: 20819630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors.
    Bojarski JD; Dupuy DE; Mayo-Smith WW
    AJR Am J Roentgenol; 2005 Aug; 185(2):466-71. PubMed ID: 16037522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation for treatment of thyroid follicular neoplasm with low SUV in PET/CT study.
    Lin WC; Tung YC; Chang YH; Luo SD; Chiang PL; Huang SC; Chen WC; Chou CK; Su YY; Chen WC; Chi SY; Baek JH
    Int J Hyperthermia; 2021; 38(1):963-969. PubMed ID: 34154505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of radiofrequency ablation therapy for thoracic malignancies with evaluation by FDG-PET.
    Higuchi M; Honjo H; Shigihara T; Shishido F; Suzuki H; Gotoh M
    J Cancer Res Clin Oncol; 2014 Nov; 140(11):1957-63. PubMed ID: 24952227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual time-point (18)F-FDG PET/CT to assess response to radiofrequency ablation of lung metastases.
    Lafuente S; Fuster D; Arguis P; Granados U; Perlaza P; Paredes P; Vollmer I; Sánchez M; Lomeña F
    Rev Esp Med Nucl Imagen Mol; 2016; 35(4):226-31. PubMed ID: 26848142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of pattern classification 24 hours after radiofrequency ablation of liver metastases on CT and positron emission tomography/CT.
    Vandenbroucke F; Vandemeulebroucke J; Ilsen B; Verdries D; Belsack D; Everaert H; Buls N; Ros PR; de Mey J
    J Vasc Interv Radiol; 2014 Aug; 25(8):1240-9. PubMed ID: 24954606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation--preliminary results.
    Suh RD; Wallace AB; Sheehan RE; Heinze SB; Goldin JG
    Radiology; 2003 Dec; 229(3):821-9. PubMed ID: 14657317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.